Showing results (81-90 of 261) with videos related to

Sort By:
Pageof 27
Nature Communications|October 30, 2022
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8<sup>+</sup> T cell immunityMiriam Rosás-Umbert, Jesper D Gunst, Marie H Pahus, et al.
Microbiome|April 12, 2022
Gut microbiome signatures linked to HIV-1 reservoir size and viremia controlAlessandra Borgognone, Marc Noguera-Julian, Bruna Oriol, et al.
Eclinicalmedicine|July 18, 2019
Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study)Beatriz Mothe, Christian Manzardo, Alvaro Sanchez-Bernabeu, et al.
Plos One|January 26, 2016
Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naïve HIV-Infected IndividualsJuan Blanco-Heredia, Aarón Lecanda, Humberto Valenzuela-Ponce, et al.
Nature Medicine|October 27, 2022
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trialLucia Bailón, Anuska Llano, Samandhy Cedeño, et al.
Mucosal Immunology|September 2, 2018
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infectionYolanda Guillén, Marc Noguera-Julian, Javier Rivera, et al.
Plos Pathogens|September 11, 2025
Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapyMaria C Puertas, Lucía Bailón, Víctor Urrea, et al.
European Journal of Immunology|March 25, 2005
Discovery and characterization of highly immunogenic and broadly recognized mimics of the HIV-1 CTL epitope Gag77-85César Boggiano, Rosa Moya, Clemencia Pinilla, et al.
Antiviral Therapy|April 14, 2010
Treatment simplification to once daily darunavir/ritonavir guided by the darunavir inhibitory quotient in heavily pretreated HIV-infected patientsJosé Moltó, Marta Valle, José Ramón Santos, et al.
Vaccines|November 18, 2020
Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c MiceNarcís Saubi, Athina Kilpeläinen, Yoshiki Eto, et al.
Pageof 27